US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...
The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental Biologics License ...
The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...
A search for a solution to the crisis in Haiti is growing more urgent as gangs gain territory and thousands more flee their homes. By Frances Robles With two months left in office, the president ...
Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...
Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...
Why the iPhone SE 4 Could Be One of Apple's Most Important Products of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback